norm: tg therapeuticsUSLEI 529900X21UKABN9NJ529 · no CIKMax severity: Low

Canonical registry

TG Therapeutics, Inc.

ent_019e4590c7b3c3fda38d5c59bae97c93

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: TG Therapeutics, Inc.
Normalized: tg therapeutics— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: 529900X21UKABN9NJ529
SEC EDGAR CIK: None — not an SEC registrant
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2024-02-29
TG Therapeutics 10-K Item 1C cybersecurity disclosure describing general risk management program, governance, and IT oversight processes. The filing explicitly states that risks from cybersecurity threats have, to date, not materially affected the Company, its business strategy, results of operations, or financial condition. No specific incident is disclosed.